Protocol Adjustment &
Financial Authorization

Form ID: OP-SAT-15M

Wholesale Access

Patient Status

NEW_CUSTOMER_VIP

Authorization

APPROVED_FOR_DISCOUNT

Expiry Lock

24 MONTHS VALIDITY

Doctor's Observation:

ATTENTION: Your 6-month "Loading Phase" is confirmed. While this is a great start, clinical data shows a biological gap.

The macula takes 12-15 months to fully saturate. Stopping at month 6 risks the "Regression Effect"—where protection levels drop back to baseline. Think of this like a course of antibiotics: if you stop halfway, the problem returns.

ACTION: We have authorized a one-time Wholesale Subsidy ($33/bottle) to upgrade you to the full 15-Month Protocol today.

EXHIBIT A: AUTHORIZED INVENTORY

Retail: $69 $33.00 PER UNIT

                         15-Month Supply
                        Priority Stock
                        +3 Bottles FREE
                    

APPROVED DISCOUNT

Item Description	Rate	Your Price
OptiVite+ (9 Bottles)	$548.00	$297.00
PROTOCOL SUBSIDY		-$251.00 OFF
SHIPPING	$12.99	FREE
TOTAL RESPONSIBILITY:		$297.00

Protocol Clarifications:

Q: Will these expire before I use them? ▼

No. This priority batch (Lot #9482-SAT) has a guaranteed shelf life of 24 months. You have 2 full years to use them, making this a safe, risk-free investment.

Q: Why do I need 15 months total? ▼

Clinical data suggests that "Macular Pigment Optical Density" peaks between months 12 and 15. Stopping early can cause regression. This pack ensures you reach the maintenance phase without interruption.

Q: Can I share this with my spouse? ▼

Yes. Many patients use this "Wholesale Access" to secure protection for their partner. 15 bottles can be split to provide 7.5 months of protection for two people.

Patient Authorization: YES! APPROVE PROTOCOL & SAVE $251

⚠️ Warning: Authorization expires if this page is closed.

[ DECLINE FINANCIAL AID: I will pay full retail price ($69/bottle) for refills and risk regression. ]

Protocol Adjustment &Financial Authorization

Doctor's Observation:

Protocol Clarifications:

Protocol Adjustment &
Financial Authorization